5 min read

Benztropine (Cogentin), Trihexyphenidyl & Parkinson's Anticholinergics: Memory, Confusion & Hallucination Risks

Why benztropine and trihexyphenidyl carry high anticholinergic burden—and how to ask a prescriber about safer tremor or EPS options without stopping abruptly.

By Tokei Health, Cognitive Health Editorial Team

Free 3-Minute Online Check · Instant Score

Draw the 11:10 clock on screen or upload a photo of a paper sheet — no signup required.

Check Your Pill List Free (rADS Burden Lookup)

When a person with Parkinson's disease or someone taking an antipsychotic medication develops sudden confusion, misplaced words, or unsettling visual hallucinations, families often assume the underlying neurological condition has abruptly worsened. Yet one of the most frequent—and reversible—culprits sits right on the daily pill list: benztropine (Cogentin) or trihexyphenidyl (Artane).

Originally introduced decades ago to calm Parkinson's tremor and medication-induced movement side effects known as extrapyramidal symptoms (EPS), these two drugs carry some of the highest anticholinergic burden scores in all of medicine. Because the aging brain naturally produces less acetylcholine, adding a strong acetylcholine blocker can tip memory, attention, and perception into sudden fog or delirium.

Understanding why these medications affect thinking—and how to prepare for a calm medication review with your prescriber—can protect both movement control and cognitive clarity.

How Benztropine and Trihexyphenidyl Affect the Brain

Inside the basal ganglia, movement smoothness depends on a delicate seesaw between dopamine and acetylcholine. When dopamine drops (as in Parkinson's disease) or dopamine receptors are blocked (as with certain antipsychotics or anti-nausea drugs), acetylcholine becomes relatively overactive, triggering tremor, muscle rigidity, or dystonia.

Benztropine and trihexyphenidyl restore balance by blocking muscarinic (M1) acetylcholine receptors. The problem is that these drugs cross the blood-brain barrier freely and block M1 receptors everywhere—not just in movement circuits:

  • Hippocampus: Blocking M1 receptors disrupts short-term memory encoding, causing repeated questions and forgotten conversations.
  • Prefrontal Cortex: Reduced cholinergic tone slows executive function, planning, and multi-step tasks (often visible on a Clock Drawing Test).
  • Visual & Arousal Networks: Excess central blockade can provoke visual hallucinations, nocturnal confusion ("sundowning"), and acute delirium.

Both medications are flagged by the American Geriatrics Society Beers Criteria as potentially inappropriate for older adults, and carry an Anticholinergic Cognitive Burden (ACB) score of 3—the maximum single-drug tier.

Warning Signs of Anticholinergic Overload

Cognitive side effects rarely appear as a neat checklist; they often look like accelerated aging or a sudden flare of Parkinson's disease dementia. Watch for a cluster of central and physical clues:

Cognitive & Perceptual Clues

  • Short-term memory gaps and repeating the same question within minutes
  • Visual hallucinations (seeing people, animals, or shadows that are not there)
  • Disorientation in familiar rooms, especially in the evening or after waking
  • Difficulty organizing numbers or spatial tasks, such as reading an analog clock or managing bills

Physical "Dry & Slow" Clues

  • Dry mouth, blurred near vision, or difficulty focusing on small print
  • New or worsening constipation and urinary retention (a major delirium trigger in older men)
  • Reduced sweating and overheating in warm weather

Comparing Parkinson's & EPS Anticholinergics vs. Other Options

The right alternative depends entirely on why the medication was started—Parkinson's tremor versus antipsychotic-induced EPS. Never adjust doses on your own; use this table to frame questions for your prescriber or pharmacist.

| Medication | Primary Use | Anticholinergic Burden | Cognitive & Safety Considerations | | :--- | :--- | :--- | :--- | | Benztropine (Cogentin) | Drug-induced EPS, Parkinson's tremor | Very High (ACB 3) | Strong M1 blockade; linked to confusion, falls, urinary retention, and hallucinations in older adults | | Trihexyphenidyl (Artane) | Parkinson's tremor, dystonia | Very High (ACB 3) | Marked central anticholinergic effects; often poorly tolerated above age 65 | | Carbidopa-Levodopa | Core Parkinson's motor symptoms | None (0) | Replaces dopamine directly instead of blocking acetylcholine; typically preferred over anticholinergics for older adults | | Amantadine | Parkinson's dyskinesia / mild symptoms | Mild–Moderate | Lower anticholinergic load than benztropine, though kidney function must be checked to avoid hallucinations | | EPS Root-Cause Adjustment | Antipsychotic-induced stiffness/akathisia | Varies | Prescribers sometimes reduce the offending dose or switch to a lower-EPS agent rather than maintaining long-term benztropine |

Why You Must Never Stop These Medications Abruptly

Even when families suspect benztropine or trihexyphenidyl is causing brain fog, do not stop either drug suddenly. Abrupt withdrawal can trigger:

  1. Rebound acute dystonia (painful muscle spasms of the neck, jaw, or eyes)
  2. Severe rigidity, tremor rebound, and sweating
  3. Cholinergic rebound with nausea, restlessness, and sleep disruption

Instead, clinicians typically use a slow, supervised taper—often while optimizing dopaminergic therapy or reassessing whether an EPS-preventing drug from years ago is still needed at all.

Five Questions to Ask Your Prescriber or Pharmacist

Before your next neurology or primary care appointment, screen the full medication list using Tokei Health's Medication & Memory Check to catch any other hidden anticholinergics (such as bladder pills or OTC sleep aids) stacking on top of benztropine. Then bring these specific questions:

  1. "Is benztropine or trihexyphenidyl still necessary, or was it started to prevent short-term EPS from an older dose?"
  2. "Could our current confusion, constipation, or hallucinations be linked to cumulative anticholinergic burden?"
  3. "If we want to reduce cognitive risk, what would a safe, gradual taper schedule look like?"
  4. "For Parkinson's tremor, would adjusting carbidopa-levodopa or another non-anticholinergic option be safer?"
  5. "Should we track memory and executive function with a simple baseline before and 4–6 weeks after any change?"

References

  • American Geriatrics Society 2023 Updated AGS Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. Journal of the American Geriatrics Society.
  • Fox C et al. Anticholinergic medication use and cognitive impairment in the older population: the Medical Research Council Cognitive Function and Ageing Study. Journal of the American Geriatrics Society.
  • Connolly BS, Lang AE. Pharmacological treatment of Parkinson disease: a review. JAMA.

Educational disclaimer: Tokei Health (Coadia, Inc.) is an educational software publisher providing self-check tools and doctor-visit preparation materials—not medical advice, diagnosis, or medical services. Never stop or change prescription medications without consulting your prescribing clinician or pharmacist.

Frequently Asked Questions

Why do benztropine and trihexyphenidyl cause memory loss and confusion in older adults?
Both medications are potent central muscarinic (M1) acetylcholine blockers. While they calm acetylcholine-driven tremor or drug-induced stiffness, they simultaneously block acetylcholine in the hippocampus and prefrontal cortex—the exact circuits needed for new memory formation, attention, and visual-spatial orientation.
Can benztropine or trihexyphenidyl trigger visual hallucinations?
Yes. High central anticholinergic load is a well-documented cause of visual hallucinations, vivid dreams, agitation, and delirium in older adults—and can mimic or worsen Lewy body dementia or Parkinson's disease psychosis.
Should I stop taking benztropine or trihexyphenidyl right away if I notice brain fog?
No. Never stop benztropine or trihexyphenidyl abruptly. Sudden discontinuation can trigger severe rebound dystonia, stiffness, sweating, or worsening tremor. Always work with your neurologist, psychiatrist, or prescriber to review alternatives and taper gradually if appropriate.
What are lower-burden alternatives a prescriber might consider?
Depending on why the medication was prescribed, clinicians often evaluate dopaminergic therapies (such as carbidopa-levodopa) for Parkinson's tremor, or adjusting the dose or agent causing extrapyramidal symptoms (EPS) rather than adding long-term anticholinergics.
Educational Self-Check

Check Your Pill List for Hidden Anticholinergic & Brain-Fog Load

Look up prescription and over-the-counter sleep, allergy, bladder, and pain pills against the clinical rADS scale — with an optional printable prescriber discussion packet to review safely with your doctor or pharmacist.

Educational self-check software: Tokei Health (Coadia, Inc.) is not a healthcare provider and does not offer medical services, diagnosis, or medical advice. Always consult a qualified physician or pharmacist before making any health or medication decisions.